In Vitro and In Silico Analysis of Chlorella
sp. CHS1 Extracellular Metabolites: An Antivibriosis Candidate for Sustainable
Aquaculture
Ating Yuniarti1,2*, Muhammad Dailami1,
Nasrullah Bai Arifin1, Rani Yuwanita1 and Anik M. Hariati1,2
1Aquaculture Study Program, Fisheries
and Marine Science Faculty, University of Brawijaya, Malang, Java, Indonesia
2Fisheries and Marine Science Doctoral
Program, Fisheries and Marine Science Faculty, University of Brawijaya, Malang,
Java, Indonesia
*For correspondence: ating_y@ub.ac.id
An isolate of Chlorella sp. CHS1 from a shrimp pond has been confirmed
morphologically and molecularly. It is necessary to understand how a candidate
for vibriosis biocontrol interacts with the Vibrio
protein. Information on the interaction of functional groups can be used to
modify the ligands and their derivatives to increase their effectiveness. The
goal of this study was to evaluate the in-vitro effect of a Chlorella sp. CHS1 on Vibrio harveyi and the interaction of
those with hemolysin protein of V. harveyi using a molecular docking
study. The extracellular metabolite of Chlorella sp. CHS1 had an inhibitory effect on V. harveyi.
Chlorella sp. extracellular metabolite increased zone inhibition as
CHS1 levels increased. The GCMS analysis revealed eight putative compounds with
greater than 80% similarity to the database. AAG25957.1 was hemolysin V. harveyi target protein used in this
study. According to the Swiss model protein modelling, the accuracy of the
protein sequence and model template reached up to 0.92. Through the evaluation
of physicochemical properties, Lipinski’s role compliance and molecular
docking, three most promising anti-vibriosis compounds were identified, i.e.,
(a) 1,2,3-propane tricarboxylic acid, 2-hydroxy, triethyl ester (ID 17), (b)
hexadecenoic acid, methyl ester (ID 28), and (c) tricosane (ID 22). Hydrophobic
and hydrogen bond interactions formed the interaction between a potential ligan
from the extracellular metabolite of Chlorella sp. CHS1 and the hemolysin protein. © 2023 Friends Science Publishers
Keywords:
Microalgae; Shrimp; V. harveyi; Vibriosis; Molecular docking; Biocontrol
Vibrio harveyi is a negative-gram bacteria that lives in aquatic
environments, particularly in tropical and warm waters (Zhang et al. 2018; Firmino et al. 2019). Many
warm-water fish and invertebrates have been linked to V. harveyi-related
diseases, including grouper (Shen et al.
2017; Zhu et al. 2018), sea bream (Haldar
et al. 2010), barramundi (Dong et
al. 2017), tiger puffer (Mohi et
al. 2010), seahorses (Raj et al.
2010; Qin et al. 2017), abalone (Wang
et al. 2018), rock lobster (Diggles
et al. 2000), shrimp (Manilal et
al. 2010; Zhou et al. 2012; Muthukrishnan et al. 2019),
and sea cucumber (Becker et al. 2004).
This bacterium has been linked to a variety of fish symptoms, including
opercula nodules, scaling, skin ulcers, tail rot, vasculitis, necrotizing
enteritis, and gastroenteritis are all symptoms (Zhang
et al. 2020). Muscular necrosis caused white or opaque lesions in
the tails of the affected shrimp (Zhou et al.
2012). V. harveyi caused significant mortality in captivity
seahorses and was identified by white spots on the surface and anorexia (Raj et al. 2010). The presence of white
spot was also detected in abalone, which was followed by pustules and foot
muscle atrophy (Wang et al. 2018).
In immunosuppressed organisms, the
severity of disease-related V. harveyi appears to be very high.
The virulence of a V. harveyi strain has been shown to be
highly dependent on the host species (Vera et
al. 1992), dose, duration of exposure, host species age (Jun and Huai-Shu 1998), and pathogenic factors
of the bacterial strain (Gomez-Gil et al. 1998; Esteve and Herrera 2000). Extracellular proteases, hemolysin,
outer membrane protein, phospholipase, and the secretion system, all played
important roles in V. harveyi pathogenesis (Austin and Zhang 2006; Natrah
et al. 2011). Hemolysin is a toxin that contributes significantly to the virulence of V. harveyi (Chattopadhyay
and Banerjee 2003; Qiao et al. 2012; Zhao et al. 2021). Protein
hemolysin has a molecular weight of 47.3 kDa and 419 amino acids (Zhong et
al. 2006; Zhao et al. 2021).
Some microalgal allelopathic
chemicals have piqued the interest of researchers due to their roles in algal
community succession and potential as biocontrol agents. Tohmola et al. (2011) reported that
microalgae produce and secrete metabolites into the medium during growth.
Carbohydrates are the most common constituent of microalgal exudates, followed
by nitrogenous compounds and vitamins (Watanabe et
al. 2008). Extensive research will be required to determine the extracellular products
of microalgae's chemical composition and mode of action. Several microalgae
have been reported to have antimicrobial activity. Chlorella sp.
produced the extracellular compound cysteine protease (ECPI-2) to protect cells
from threats such as viruses and herbivorous animals (Ishihara et al. 2006). Chlorella sp. extracellular
fluid can also be used against Pseudokirchneriella subcapitata (DellaGreca et al. 2010). Natrah et al. (2011) discovered
that extracts from Chlorella vulgaris CCAP211/12 and C. saccharophila
CCAP211/48 inhibited QS-regulated violacein production in
CV026 indicating the presence of N-hexanoyl homoserine lactone.
Chlorella sp. CHS1 has been identified
morphologically and molecularly as
a species of microalgae indigenous to shrimp ponds. The potential biocontrol of
vibriosis caused by V. harveyi by an extracellular metabolite of Chlorella
sp. CHS1 was investigated. Knowing how a candidate for vibriosis biocontrol
interacts with the virulence protein is important when considering a candidate
for vibriosis biocontrol. The goal of this study was to evaluate the in-vitro
effect of a Chlorella sp. CHS1 extracellular metabolite on V. harveyi
and the interaction of those with the hemolysin protein from V. harveyi
using a molecular docking study.
Culture of
microalgae
Chlorella sp. CHS1 from ponds in the Situbondo
area was used in this study for microalgae culture. Cultures of Chlorella
sp. CHS1 have been identified morphologically and molecularly. Chlorella
sp. CHS 1 was grown in Walne medium (Jayasankar
and Valsala 2008) at 25°C, pH 7, 25 ppt salinity, and a light intensity
of 4,500 lux.
Extraction
of extracellular metabolites of Chlorella sp. CHS1
The method of Natrah et al. (2011) for preparing of algal supernatant extract for microalgae
was used.
During the late stationary period, algae were harvested. The culture was
centrifuged for 5 min at 5000 rpm, and the supernatant was collected at -20°C. A 10 mL
of the Chlorella sp. supernatant was thoroughly mixed with 10 mL of
ethyl acetate. The solution was centrifuged at 3000 rpm for 10 min, and the
ethyl acetate fraction was collected. This extraction was carried out twice.
The sample was then evaporated at 30°C dissolved in 100 µL of 100%
acetonitrile, and finally diluted with 300 µL of ddH2O. All samples
should be stored at -20°C in glass sample vials until use.
In vitro analysis
This study
was conducted to evaluate antimicrobial growth against V. harveyi, which was cultured for 24 h in 10
mL of TSB containing 2% of NaCl at 30℃. The broth was washed and suspended with
PBS after being centrifuged at 2000 rpm (pH 7, 2). This bacterial suspension (1
mL) was placed in a TSA plate containing 2% NaCl. TSA wells were formed, and 10
μL of Chlorella
sp. extracellular metabolites was added.
The plates were incubated at 30°C
for 24 and 48 h, and the zones of inhibition around the wells were measured at
both times.
GC-MS
analysis
Gas chromatography-mass spectrometry
(GC-MS) analysis was performed using an Agilent Technologies-7890A gas chromatograph
with a mass-selective detector (5975C NICI-MS). A capillary column DB-5HT was
used in the chromatography system (30 mm ´ 0.320 mm, film thickness 0.10 m).
The injection was carried out automatically at a temperature of 250°C in the
injector. The programmed temperature was applied with column starting at 180°C,
and gradually increasing by 50°C per min until it reached 325°C and held there
for 1 min. In split-less mode, helium gas (99.99% purity) is used as the
carrier gas, with a constant flow rate of 3.5 mL.min-1 (1 L).
In silico analysis
Homology
modeling of hemolysin protein: The SWISS-MODEL template library was searched for template using BLAST (Camacho et al. 2009; Bienert et al. 2017). BLAST
was used to search the target sequence of the V. harveyi (AAG25957.1)
against the primary amino acid sequence in the database (Zhang et al.
2001). A total of eight templates were discovered. Models were created
using the target-template alignment. The QMEANDisCo scoring function was used
to evaluate the global and per-residue model (Studer
et al. 2020).
Preparation
of the ligand: In
the current docking study, several identified compounds from Chlorella
sp. CHS1 extracellular metabolite were used. PubChem (http://pubchem.ncbi.nlm.nih.gov)
was used to download the 3D structures. The inhibitor molecule was given the
Gasteiger and Kollman united atom charges. The 3D structures were minimized to
obtain the most stable energy and then converted to *.pdb format with open
babel oftware (O’Boyle et al. 2011)
and compiled in Pyrx 0.8.
Molecular
docking and ligan interaction: The Auto Dock Vina program (Trott and
Olson 2010) compiled in Pyrx software was used for molecular docking. To
evaluate the ligand binding energies across the conformational search space,
the Lamarckian genetic algorithm was used. A polar hydrogen atom was added to
the receptor protein. The active site of the protein accommodated in the
docking was defined by a grid box region of 25 ´ 25 ´ 25 with a 0.375 Å span and center
coordinates of x (204.54), y (15.42), z (34.74). The interaction of Ligan
protein was investigated using Discovery Studio tools. SwissADME web-based
platform (http://www.swissadme.ch/) was used to analyze the physicochemical
properties and fulfillment of Lipinski’s (Daina et
al. 2017).
In vitro analysis
The antimicrobial properties of Chlorella
sp. CHS1 extracellular metabolites were tested against V. harveyi using
a well diffusion assay. Table 1 shows the results of the antagonism assays used
in this study. The
zone inhibition increased as the concentration of extracellular metabolites of Chlorella
sp. CHS1
increased, according to the well diffusion assay. As a control, there was no
zone of inhibition. After 48 h, the inhibitory zones in all concentrations were
reduced by 5.86–29.76%.
GM-MS analysis
The GC-MS analysis of Chlorella sp. extracellular metabolites CHS1 was successful in detecting 41 different
of active compounds. The active compounds were identified using a comparison of
retention time and mass spectrum in the GC-MS library (Fig. 1). Only eight
putative compounds shared more than 80% similarity with the C-MS library
database (Table 2). Following that, the eight compounds were chosen for
molecular docking analysis.
Homology modeling of protein
hemolysin V. harveyi
Hemolysin, which play an important
role in the virulence of V. harveyi, has the ability to lyse red blood
cells by creating pores in the cytoplasmic membrane. The amino acid sequence of
the V. harveyi hemolysin protein, accession number of AAG25957.1,
was obtained from the Gen Bank (Zhang et al.
2001). Three-dimensional (3D) structure modeling was performed using the
Swiss model (https://swissmodel.expasy.org/) and a template from V.
vulnificus protein hemolysin. There were eight protein structures
from a protein database (pdb) with sequence identities ranging from 75.36 to
76.79% (data were not shown). Model 7 was chosen as the best model based on the
highest QMEANDisCoGlobal value (0.90) among the other models. The
alignment of the amino acid sequence of V. harveyi hemolysin protein and
the template model (PDB ID 6jl2.2.A) is shown in Fig. 2. The Ramachandran plot
was used to assess the structure quality of the modeled hemolysin protein
(model 7). Fig. 3a–b show the 3D structure of the modeled hemolysin protein as
well as the Ramachadran plot result. According to the Ramachandran plot
analysis, 97.37% of the amino acids in that protein were in the favored region.
The
molecular docking and ligand interaction
The
docking analysis revealed that seven (7) compounds and the naturally occurring
ligand (hexa-ethylene glycol) could bind to the same active site of the
hemolysin protein. However, butylated hydroxytoluene (ID11) was unable to bind
to the same active site. Fig. 4 depicts the binding positions of eight (8)
putative compounds and the natural ligand for the hemolysin protein. Table 3
shows the binding affinity of eight putative compounds and natural ligands with
hemolysin V. harveyi. There were five compounds with lower binding
affinity values than natural ligands (hexa-ethylene glycol); (1) Hexadecanoic acid, methyl ester, (2) Heneicosane, (3)
Docosane, (4) Tetracosane and (5) Tricosane. This suggested that those five
compounds are potential inhibitors of V. harveyi protein hemolysin. The
ADME (adsorption, distribution, metabolism and elimination) related physicochemical
and pharmacokinetic properties were evaluated using SwissADME (Daina et al. 2017) (http://www.swissadme.ch/). Table
4 shows the psychochemical and pharmacokinetic properties of the eight putative
compounds. The scoring was done based on the value of binding energy, Lipinski
violation, bioavailability, and potential for chemical synthesis to select the
compound with high potential (Table 5). The scoring results ranged from 24.84
to 26.97. (1) 1,2,3-propanetricarboxylic acid, 2-hydroxy-, triethyl ester, (2)
hexadecanoic acid, (3) tricosane were the top three candidates for anti-vibriosis
compounds. Various chemical interactions can cause a ligan to bind to the
target protein. To discover this relationship, the discovery studio was used to
analyze how ligands and receptors interact. Previous research suggested that
the three chemicals might have anti-vibrio properties. Fig 5 depicts the
interactions of these three compounds with the hemolysin protein of V.
harveyi.
The zone inhibition increased as the amount
of Chlorella sp. extracellular metabolites increased. This decrease
demonstrated that Chlorella sp. extracellular metabolites CHS1 is
bacteriostactic (suppresses growth) rather than bacteriocidal (kills bacteria).
High cell
density microalgae cultures were discovered to excrete growth inhibitors into
supernatant, as previously reported in Nannochloropsis sp (Richmond and Zou 1999) and C.
vulgaris (Javanmardian and Palsson 1991).
Diatom extracellular polyunsaturated aldehydes also influenced bacterial
development (Ribalet et al. 2008).
However, depending on the type of bacteria, these chemicals have varying
effects on bacterial growth, either suppressing or stimulating. Natrah et al. (2011) discovered no
evidence of inhibitory growth activity caused by the cell-free supernatant of
microalgal cultures. The chemicals, on the other hand, inhibited
acyl-homoserine lactone-regulated violacein production and bioluminescence in
the aquaculture pathogen V. harveyi. Haloperoxidase enzyme Table 1: Extracellular metabolites of Chlorella sp CHS1
were evaluated in vitro
Concentration
of Chlorella sp extracellular metabolites (µg.mL-1) |
Inhibitory zone (mm) at |
|
24 h |
48 h |
|
1 |
0.93±0.10 |
0.66±0.17 |
10 |
3.03±0.06 |
2.85±0.06 |
100 |
3.97±0.26 |
3.67±0.25 |
1000 |
5.89±0.21 |
5.41±0.22 |
DMSO |
0.00±0.00 |
00.0±0.00 |
Mean ± standard deviation
Table 2: The putative compounds derived from Chlorella sp. CHS1extracellular
metabolites
No |
ID |
RT |
Area (%) |
Library/ID |
Quality |
MF |
MW (g.mol-1) |
1 |
33 |
17.805 |
3.44 |
Heneicosane |
96 |
296.6 |
|
2 |
40 |
21.449 |
4.95 |
Docosane |
98 |
310.6 |
|
3 |
22 |
11.337 |
9.97 |
Tricosane |
99 |
324.6l |
|
4 |
34 |
18.715 |
11.91 |
Tetracosane |
97 |
338.7 |
|
5 |
28 |
13.828 |
2.8 |
Hexadecanoic acid, methyl ester |
90 |
270.5 |
|
6 |
11 |
9.454 |
4.22 |
Butylated Hydroxytoluene |
98 |
220.35 |
|
7 |
26 |
13.093 |
20 |
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl)
ester |
86 |
278.34 |
|
8 |
17 |
10.639 |
6.38 |
1,2,3-Propanetricarboxylic acid, 2 -hydroxy-, triethyl
ester |
86 |
276.28 |
RT: retention time, MF: molecular formula, MW:
molecular weight
Fig. 1:
Chlorella sp. CHS1
extracellular metabolites GC-MS analysis
Fig. 2: The amino acid sequences alignment of
V. harveyi and template V. vulnificus hemolysins (6jl2.2.A)
from diatoms also interfered with quorum sensing by halogenating the
acyl side chain and preventing AHL binding to the quorum sensing regulator (Amin et al. 2012).
Molecular docking, using
either structure-based or ligand-based methods, has played an important role in
the development of therapeutically important small molecules (Sliwoski et al. 2014). When the crystal
structure of a protein cannot be determined empirically, homology modelling is
used. Schmidt et al. (2014)
demonstrated how modeling could result in precise target prediction in drug
designing activity.
Virtual screening of bioactive molecules is essential for weeding out
potentially effective drugs in preclinical development.
According to
Lipinski's rule, drug compounds that meet the criteria can penetrate cell
membranes and be absorbed in the body: (1) a molecular weight (MW) <500 Table 3: The
putative compounds derived from Chlorella sp. CHS1 extracellular metabolites
No |
Compound ID |
Molecular Formula |
Affinity (kkal/mol-1) |
1 |
28 |
Hexadecanoic acid, methyl ester |
−7.1 |
2 |
33 |
Heneicosane |
−6.5 |
3 |
40 |
Docosane |
−6.4 |
4 |
34 |
Tetracosane |
−6.3 |
5 |
22 |
Tricosane |
−6.2 |
6 |
17 |
1,2,3-Propanetricarboxylic acid, 2
-hydroxy-, triethyl ester |
−5.1 |
7 |
26 |
1,2-Benzenedicarboxylic acid,
bis(2-methylpropyl) ester |
−5.1 |
8 |
11 |
Butylated Hydroxytoluene |
−3.9 |
9 |
Natural ligand |
Hexaethylene glycol |
−5.4 |
Table 4: The psychochemical properties of eight potential Chlorella sp.
Compounds SwissADME-based CHS1
ID |
Molecular Formula |
MW |
H-bond acceptors |
H-bond donors |
Consensus Log P |
ESOL Log S |
Violation of Lipinski |
Bioavailability |
Synthetic Accessibility |
11 |
C15H30O |
249.58 |
1 |
1 |
3.71 |
-4.32 |
0 |
0.55 |
4.19 |
17 |
C12H20O7 |
295.43 |
7 |
1 |
0.80 |
-0.99 |
0 |
0.55 |
3.63 |
22 |
C23H48 |
324.63 |
0 |
0 |
9.00 |
-8.14 |
1 |
0.55 |
3.08 |
26 |
C16H28O4 |
306.57 |
4 |
0 |
3.19 |
-3.85 |
0 |
0.55 |
4.51 |
28 |
C17H34O2 |
304.72 |
2 |
0 |
5.42 |
-5.39 |
1 |
0.55 |
3.89 |
33 |
C21H44 |
340.92 |
0 |
0 |
8.08 |
-7.69 |
1 |
0.55 |
4.66 |
34 |
C24H50 |
338.65 |
0 |
0 |
9.35 |
-8.50 |
1 |
0.55 |
3.20 |
40 |
C22H46 |
310.60 |
0 |
0 |
8.64 |
-7.78 |
1 |
0.55 |
2.96 |
Fig. 3: (a)
The 3D structure of V. harveyi hemolysin protein model (b). The
Ramachandran plot’s outcome
Fig. 4: (a)
The natural ligand’s pose and binding position (hexa-ethylene glycol), (b) the
seven putative compounds from Chlorella sp. extracellular metabolites of CHS1
grams.mol−1,
(2) a hydrogen bond proton donor group <5, (3) a hydrogen bond proton
acceptor group <10, and (4) the logarithm value of the partition coefficient
in water and 1-octanol <5 (Lipinski et al.
2012). Table 4 shows that the chemicals with the ID numbers 11, 17 and
26 did not violate Lipinski’s role. Meanwhile, the other chemicals violated
Lipinski's role (ID 22, 28, 33, 34 and 40). The ability of a drug compound to
absorb and circulate in the body is referred to as bioavailability
(Daina et al. 2017). The SwissADME
predictions revealed that all compounds identified in this study have a
bioavailability value of 0.55, indicating a high possibility of absorption in
the body. Synthetic accessibility (SA) score is based on the assumption that
the frequency of molecular fragments in “truly” attainable compounds correlates with
the ease of synthesis (Daina et al. 2017).
Furthermore, the SA score should be between 1 to 10. The higher the value, the
more difficult it is for compound to be chemically synthesized. The SA values
of the eight putative Chlorella sp. compounds CHS1 ranged between 2.96
to 4.66. Docosane (ID 40) was the simplest to synthesize, while Heneicosane was
the most difficult (ID 33).
The
biological activity was thought to be caused by both H-bond and hydrophobic
interactions between the ligands/inhibitors and the active regions of the
receptor (Madeswaran et al. 2012).
The interactions that occurred between the ligand and the hemolysin protein in
this study were hydrogen bond (H-bond) and hydrophobic. According to Fig. 5,
the compound 1,2,3-Propanetricarboxylic acid, 2-hydroxy, triethyl ester, and
protein hemolysin were able to form five hydrogen bonds and ten hydrophobic
interactions. ASN248, HIS393, THR392 and PRO394 amino acids were used to form
hydrogen bonds. The methyl ester of hexadecenoic acid could form five hydrogen
bonds and seven hydrophobic interactions. ASN248, ASN 252, TYR368, THR392 and
ASN252 were the active sites of the residues involved. Furthermore, 28
hydrophobic interactions were found for tricosane, indicating that ligan can
bind to the hemolysin protein. Small compounds bound to the target protein
pocket via H-bonds and hydrophobic interactions may be able to prevent the
conformational changes that result in fusion (Sivakumar
et al. 2021). Although larger conformational changes degrade
performance, smaller ligand-induced protein movements appear to have little
effect on rigid docking performance (Verdonk et al. 2008). It was discovered that a flavonoid
(found in papaya, apple and lemon) with anti-dengue activity could halt the
dengue virus fusion process by impeding the movement of the hinge area and
obstructing the conformational rearrangement in envelope protein (Mir et al. 2016).
The
drug for neutralizing a target protein of Vibrio spp. was predicted
using a molecular docking study against vibriosis. Sivakumar et al. (2021) used a compound from Ulva
fasciata extract in a molecular docking study against the hemolysin protein
V. harveyi. They discovered that methyl dehydroabietate had the highest
binding affinity on the active pocket of hemolysin protein. Arunkumar et al. (2017) investigated
several natural substances for their ability to suppress Vibrio
hemolysin. Cyanidin and Bergapten have been identified as potential compounds
for the development of novel and potentially effective drugs to treat
vibriosis. Boronic acid derivatives bind to the binding site of the LuxP
protein, according to V. harveyi, Rajamanikandan and Jeyakanthan (2017). The
chemical inhibitor of V. harveyi biofilm development was discovered to
be [2.2.1] hept-5-ene-2,3-dicarboxylic acid-2,6-dimethylpyridine 1-oxide.
An in
vitro study revealed that the
extracellular metabolites of Chlorella sp. CHS1 is bacteriostactic (growth
suppressing) in a dose dependent manner. According to the virtual
screening analysis using molecular docking, physiochemistry criteria, and Lipinski's drug
similarity rule, three potential anti-vibrio compounds exist;
1,2,3-Propanetricarboxylic acid, 2 -hydroxy-, triethyl ester), Hexadecenoic
acid, methyl ester), and Tricosane. The potent compounds interact with the
hemolysin protein V. harveyi via hydrogen bond and hydrophobic
interactions.
University of Brawijaya funded this study with grant
number: 90/UN1/DITLIT/DIT-LIT/LT/2017.
ATY designed the experiment and wrote the
paper. MD carried out the in-silico analysis. The microalgae culture,
extracellular metabolites, GC-MS analysis, and in-vitro study were prepared by
NBA and RY. AMH reviewed the manuscript and analyzed the data.
Conflicts of Interest
This research has no potential conflict of interest.
Data Availability
The data described in this work will be made
available upon reasonable request to the corresponding author.
Ethics Approval
Not applicable in this study.
Amin SA, MS Parker, EV Armbrust (2012). Interactions between
diatoms and bacteria. Microbiol Mol Biol Rev 76:667–684
Arunkumar T, K Archana Vasuki, G Narendrakumar (2017). In
silico analysis on docking studies of haemolysin protein in vibrio
paraheamolyticus. Biomed Pharmacol J 10:1879–1886
Austin B, XH Zhang (2006). Vibrio harveyi: A
significant pathogen of marine vertebrates and invertebrates. Lett Appl
Microbiol 43:119–124
Becker P, D Gillan, D Lanterbecq, M Jangoux, R
Rasolofonirina, J Rakotovao, I Eeckhaut (2004). The skin ulceration disease in
cultivated juveniles of Holothuria scabra (Holothuroidea,
Echinodermata). Aquaculture 242:13–30
Bienert S, A Waterhouse, TAP De Beer, G Tauriello, G Studer,
L Bordoli, T Schwede (2017). The SWISS-MODEL Repository-new features and
functionality. Nucl Acids Res 45:D313–D319
Camacho C, G Coulouris, VMAN Avagyan, J Papadopoulos, K
Bealer, TL Madden (2009). BLAST+: Architecture and applications. BMC
Bioinform 10:1–9
Chattopadhyay K, KK Banerjee (2003). Unfolding of Vibrio
cholerae hemolysin induces oligomerization of the toxin monomer. J Biol Chem
278:38470–38475
Daina A, O Michielin, V Zoete
(2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and
medicinal chemistry friendliness of small molecules. Sci Rep 7:42717
DellaGreca M, A Zarrelli, P
Fergola, M Cerasuolo, A Pollio, G Pinto (2010). Fatty acids released by Chlorella vulgaris
and their role in interference with Pseudokirchneriella subcapitata:
Experiments and modelling. J Chem Ecol 36:339–349
Diggles BK, GA Moss, J Carson, CD Anderson (2000). Luminous
vibriosis in rock lobster Jasus verreauxi (Decapoda: Palinuridae) Phyllosoma
larvae associated with infection by Vibrio harveyi. Dis Aquat Org
43:127–137
Dong HT, S Taengphu, P Sangsuriya, W Charoensapsri, K
Phiwsaiya, T Sornwatana, P Khunrae, T Rattanarojpong, S Senapin (2017).
Recovery of Vibrio harveyi from scale drop and muscle necrosis disease
in farmed barramundi, Lates calcarifer in Vietnam. Aquaculture 473:89–96
Esteve M, FC Herrera (2000). Hepatopancreatic alterations in Litopenaeus
vannamei (Boone, 1939) (Crustacea: Decapoda: Penaeidae) experimentally
infected with a Vibrio alginolyticus strain. J Invert Pathol
76:1–5
Firmino J, MD Furones, KB Andree, C Sarasquete, JB
Ortiz-Delgado, G Asencio-Alcudia, E Gisbert (2019). Contrasting outcomes of Vibrio
harveyi pathogenicity in gilthead seabream, Sparus aurata and European
seabass, Dicentrachus labrax. Aquaculture 511:734210
Gomez-Gil B, L Tron-Mayen, A Roque, JF Turnbull, V Inglis, AL
Guerra-Flores (1998). Species of Vibrio isolated from hepatopancreas,
haemolymph and digestive tract of a population of healthy juvenile Penaeus
vannamei. Aquaculture 163:1–9
Haldar S, A Maharajan, S Chatterjee, SA Hunter, N Chowdhury,
A Hinenoya, M Asakura, S Yamasaki (2010). Identification of Vibrio harveyi
as a causative bacterium for a tail rot disease of sea bream Sparus aurata
from research hatchery in Malta. Microbiol Res 165:639–648
Ishihara M, T Shiroma, T Taira, S Tawata (2006). Purification
and characterization of extracellular cysteine protease inhibitor, ECPI-2, from
Chlorella sp. J Biosci Bioeng 101:166–171
Javanmardian M, BO Palsson (1991). High‐density photoautotrophic
algal cultures: Design, construction, and operation of a novel photobioreactor
system. Biotechnol Bioeng 38:1182–1189
Jayasankar R, KK Valsala (2008). Influence of different
concentrations of sodium bicarbonate on growth rate and chlorophyll content of Chlorella
salina. J Mar Biol Assoc Ind 50:74–78
Jun LI, X Huai-Shu (1998). Isolation and biological
characteristics of Vibrio harveyi affecting hatchery reared Penaeus
chinensis larvae. Chin J Oceanol Limnol 29:353–361
Lipinski CA, F Lombardo, BW Dominy, PJ Feeney (2012).
Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Adv Drug Deliv Rev
64:4–17
Madeswaran A, M Umamaheswari, K Asokkumar, T Sivashanmugam, V
Subhadradevi, P Jagannath (2012). Discovery of potential aldose reductase
inhibitors using in silico docking studies. Oriental Pharm Exp Med
12:157–161
Manilal A, S Sujith, J Selvin, C Shakir, R Gandhimathi
(2010). Virulence of vibrios isolated from diseased Black Tiger Shrimp, Penaeus
monodon, Fabricius. J World Aquacult Soc 41:332–343
Mir A, H Ismatullah, S Rauf, UHK
Niazi (2016). Identification of bioflavonoid as fusion inhibitor of dengue virus using
molecular docking approach. Inform Med Unlocked 3:1–6
Mohi MM, M Kuratani, T Miyazaki, T Yoshida (2010).
Histopathological studies on Vibrio harveyi-infected tiger puffer,
takifugu rubripes (temminck et schlegel), cultured in Japan. J Fish Dis
33:833–840
Muthukrishnan S, T Defoirdt, MY Ina-Salwany, FM Yusoff, M
Shariff, SI Ismail, I Natrah (2019). Vibrio parahaemolyticus and Vibrio
harveyi causing Acute Hepatopancreatic Necrosis Disease (AHPND) in Penaeus
vannamei (Boone, 1931) isolated from Malaysian shrimp ponds. Aquaculture
511:734227
Natrah FMI, MM Kenmegne, W Wiyoto, P Sorgeloos, P Bossier, T
Defoirdt (2011). Effects of micro-algae commonly used in aquaculture on
acyl-homoserine lactone quorum sensing. Aquaculture 317:53–57
O’Boyle NM, M Banck, CA James, C Morley, T Vandermeersch, GR Hutchison
(2011). Open babel: An open chemical toolbox. J Chemiinform 3:33
Qiao G, H Li, D Xu, SIl Park
(2012). Modified a colony forming unit microbial adherence to hydrocarbons assay
and evaluated cell surface hydrophobicity and biofilm production of Vibrio
scophthalmi. Bacteriol Parasitol 3:1–6
Qin G, X Wang, S Tan, Q Lin (2017). A bacterial infection by Vibrio
harveyi causing heavy reduction of cultured lined seahorse Hippocampus
erectus. J Fish Dis 40:601–605
Raj ST, AP Lipton, GS Chauhan (2010). Characterization and
infectivity evaluation of Vibrio harveyi causing white patch disease
among captive reared seahorses, Hippocampus kuda. Ind J Mar Sci
39:151–156
Rajamanikandan S, J Jeyakanthan (2017). Molecular docking,
molecular dynamics simulations, computational screening to design quorum
sensing inhibitors targeting LuxP of Vibrio harveyi and its biological
evaluation. Appl Biochem Biotechnol 181:192–218
Ribalet F, L Intertaglia, P Lebaron, R Casotti (2008).
Differential effect of three polyunsaturated aldehydes on marine bacterial isolates.
Aquat Toxicol 86:249–255
Richmond A, N Zou (1999). Efficient utilisation of high
photon irradiance for mass production of photoautotrophic micro-organisms. J
Appl Phycol 11:123–127
Schmidt T, A Bergner, T Schwede (2014). Modelling three-dimensional
protein structures for applications in drug design. Drug Discov Today
19:890–897
Shen GM, CY Shi, C Fan, D Jia, SQ Wang, GS Xie, GY Li, ZL Mo,
J Huang (2017). Isolation, identification and pathogenicity of Vibrio
harveyi, the causal agent of skin ulcer disease in juvenile hybrid groupers
Epinephelus fuscoguttatus × Epinephelus lanceolatus. J Fish
Dis 40:1351–1362
Sivakumar K, S Kannappan, B Vijayakumar, P Jithendran,
Karingalakkandy, S Balasubramaniam, A Panigrahi (2021). Molecular docking study
of bio-inhibitors extracted from marine macro-alga Ulva fasciata against
hemolysin protein of luminescence disease-causing Vibrio harveyi. Arch
Microbiol 203:4243–4258
Sliwoski G, S Kothiwale, J Meiler, EW Lowe (2014).
Computational methods in drug discovery. Pharmacol Rev 66:334–395
Studer G, C Rempfer, AM Waterhouse, R Gumienny, J Haas, T
Schwede (2020). QMEANDisCo—distance constraints applied on model quality
estimation. Bioinformatics, 36:1765–1771
Tohmola N, J Ahtinen, JP Pitkänen, V Parviainen, S Joenväärä,
M Hautamäki, P Lindroos, J Mäkinen, R Renkonen (2011). On-line high performance
liquid chromatography measurements of extracellular metabolitesin an aerobic
batch yeast (Saccharomyces cerevisiae) culture. Biotechnol Bioprocess
Eng 16:264–272
Trott O, AJ Olson (2010). AutoDock Vina:
Improving the speed and accuracy of docking with a new scoring function,
efficient optimization, and multithreading. J Comput Chem 31:455–461
Vera P, JI Navas, MC Quintero
(1992). Experimental study of the virulence of three species of Vibrio
bacteria in Penaeus japonicus (Bate 1881) juveniles. Aquaculture
107:119–123
Verdonk ML, PN Mortenson, RJ Hall, MJ Hartshorn, CW Murray
(2008). Protein-ligand docking against non-native protein conformers. J Chem
Inform Model 48:2214–2225
Wang R, T Yao, X Liu, J Wang
(2018). Isolation and characterisation of Vibrio harveyi as etiological
agent of foot pustule disease in the abalone Haliotis discus hannai Ino
1953. Ind J Fish 65:79–85
Watanabe K, M Imase, H Aoyagi, N Ohmura,
H Saiki, H Tanaka (2008). Development of a novel artificial medium based on utilization
of algal photosynthetic metabolites by symbiotic heterotrophs. J Appl
Microbiol 105:741–751
Zhang XH, PG Meaden, B Austin (2001). Duplication of
hemolysin genes in a virulent isolate of Vibrio harveyi. Appl Environ
Microbiol 67:3161–3167
Zhang XH, X He, B Austin (2020). Vibrio harveyi: A
serious pathogen of fish and invertebrates in mariculture. Mar Life Sci
Technol 2:231–245
Zhang XH, H Lin, X Wang, B Austin (2018). Significance of Vibrio
species in the marine organic carbon cycle—A review. Sci Chin Earth Sci
61:1357–1368
Zhao X, Y Guo, J He, J Liu, S Ye (2021). Gastrodin relieves Vibrio
harveyi infection by blocking hemolysin active centers. Aquaculture
544:737056
Zhong Y, XH Zhang, J Chen, Z Chi, B Sun, Y Li, B Austin
(2006). Overexpression, purification, characterization, and pathogenicity of Vibrio
harveyi hemolysin VHH. Infect Immun 74:6001–6005
Zhou J, W Fang, X Yang, S Zhou, L
Hu, X Li, X Qi (2012). A nonluminescent and highly virulent Vibrio harveyi
strain is associated with “Bacterial White Tail Disease" of Litopenaeus
vannamei Shrimp. PLoS One 7:e29961
Zhu ZM, CF Dong, SP
Weng, JG He (2018). The high prevalence of pathogenic Vibrio harveyi
with multiple antibiotic resistance in scale drop and muscle necrosis disease
of the hybrid grouper, Epinephelus fuscoguttatus (♀) × E.
lanceolatus (♂), in China. J Fish Dis 41:589–601